LYEL - Wall Street Estimates - Lyell Immunopharma, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.5755

2.97 %

$ 168 M

Market Cap

-0.73

P/E

Price Target Average

812.25%

Revenue Forecast Estimate

--66.67%

EBIT Estimate

99.98%

Net Income Estimate

35.11%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Lyell Immunopharma, Inc.

Wall Street analysts predict an average 1-year price target for LYEL of $5.25 , with forecasts ranging from a low of $1 to a high of $12 .

LYEL Lowest Price Target Wall Street Target

1 USD 73.76%

LYEL Average Price Target Wall Street Target

5.25 USD 812.25%

LYEL Highest Price Target Wall Street Target

12 USD 1985.14%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free